¹H MR Spectroscopic Characteristics of Kernicterus: A Possible Metabolic Signature

References

1. ↵
   Hansen TWR. Kernicterus: an international perspective. Semin Neonatol 2002;7:103–109

   CrossRefPubMed
2. ↵
   Johnson LH, Bhutani VK. System-based approach to management of neonatal jaundice and prevention of kernicterus. J Pediatr 2002;140:396–403

   CrossRefPubMedWeb of Science
3. ↵
   Yu MW, Hsiao KJ, Wuu KD, Chen CJ. Association between glucose-6-phosphate dehydrogenase deficiency and neonatal jaundice: interaction with multiple risk factors. Int J Epidemiol 1992;21:947–952

   Abstract/FREE Full Text
4. ↵
   Kaplan M, Hammerman C. Glucose-6-phosphate dehydrogenase deficiency: a potential source of severe neonatal hyperbilirubinaemia and kernicterus. Semin Neonatol 2002;7:121–128

   CrossRefPubMed
5. ↵
   Cashore WJ. Bilirubin metabolism and toxicity in the newborn. In: Polin PA, Fox WW, eds. Fetal and neonatal physiology. Philadelphia: W. B. Saunders;1998 :1493–1498
6. ↵
   Vert P, Grojean S. The toxicity of bilirubin to the central nervous system. Arch Pediatr 2002;9:1074–1077

   PubMed
7. ↵
   Wennberg RP. The blood-brain barrier and bilirubin encephalopathy. Cell Mol Neurobiol 2000;20:97–109

   CrossRefPubMedWeb of Science
8. ↵
   Schmorl G. Zur Kenntnis des ikterus neonatorum, insbesondere der dabei auftretenden Gehirnveranderungen. Verh Dtsch Ges Pathol 1904;6:109–115
9. ↵
   Shapiro SM. Bilirubin toxicity in the developing nervous system. Pediatr Neurol 2003;29:410–421

   CrossRefPubMedWeb of Science
10. ↵
    Cremer RJ, Perryman PW, Richards DH. Influence of light on the hyperbilirubinemia of infants. Lancet 1958;1:1094–1097

    CrossRefPubMedWeb of Science
11. ↵
    Labrune P. Severe hyperbilirubinemia in the newborn: definition and management. Arch Pediatr 1998;5:1162–1167

    PubMed
12. ↵
    Sugama S, Soeda A, Eto Y. Magnetic resonance imaging in three children with kernicterus. Pediatr Neurol 2001;25:328–331

    CrossRefPubMedWeb of Science
13. ↵
    Steinborn M, Seelos KC, Heuck A, et al. MR findings in a patient with kernicterus. Eur Radiol 1999;9:1939–1915
14. ↵
    Govaert P, Lequin M, Swarte R, et al. Changes in globus pallidus with (pre)term kernicterus. Pediatrics 2003;112:1256–1263

    Abstract/FREE Full Text
15. ↵
    Silva R, Mata L, Gulbenkian S, et al. Inhibition of glutamate uptake by unconjugated bilirubin in cultured cortical rat astrocytes: role of concentration and pH. Biochem Biophys Res Comm 1999;265:67–72

    CrossRefPubMed
16. ↵
    Provencher S. Estimation of metabolite concentrations from localized in vivo proton NMR spectra. Magn Reson Med 1993;30:672–679

    CrossRefPubMedWeb of Science
17. ↵
    Kreis R, Hofmann L, Kuhlmann B, et al. Brain metabolite composition during early human brain development as measured by quantitative in vivo ¹H magnetic resonance spectroscopy. Magn Reson Med 2002;48:949–958

    CrossRefPubMedWeb of Science
18. ↵
    Neter J, Wasserman W, Kutner MH. Applied linear statistical models. 2nd ed. Homewood, IL: Irwin;1985
19. ↵
    McDonald J, Shapiro S, Silverstein F, Johnston M. Role of glutamate receptor-mediated excitotoxicity in bilirubin-induced brain injury in the Gunn rat model. Exp Neurol 1998;150:21–29

    CrossRefPubMedWeb of Science
20. ↵
    Grojean S, Koziel V, Vert P, Daval J. Bilirubin induces apoptosis via activation of NMDA receptors in developing rat brain neurons. Exp Neurol 2000;166:334–341

    CrossRefPubMedWeb of Science
21. ↵
    Saransaari P, Oja SS. Taurine and neural cell damage. Amino Acids 2000;19:509–526

    CrossRefPubMedWeb of Science
22. ↵
    Saransaari P, Oja SS. Modulation of taurine release by glutamate receptors and nitric oxide. Prog Neurobiol 2000;62:407–425

    CrossRefPubMedWeb of Science
23. ↵
    Cecil KM, Jones BV. MR Spectroscopy of the pediatric brain. Top Magn Reson Imaging 2001;12:435–452

    CrossRefPubMed
24. ↵
    Jenkins BG, Kraft E. Magnetic resonance spectroscopy in toxic encephalopathy and neurodegeneration. Curr Opin Neurol 1999;12:753–760

    CrossRefPubMed
25. ↵
    Cordoba J, Sanpedro F, Alonso J, Rovira A. 1H magnetic resonance in the study of hepatic encephalopathy in humans. Metab Brain Dis 2002;17:415–429

    CrossRefPubMedWeb of Science
26. ↵
    Kreis R, Ross BD, Farrow NA, Ackerman Z. Metabolic disorders of the brain in chronic hepatic encephalopathy detected with H-1 MR spectroscopy. Radiology 1992;182:19–27

    PubMedWeb of Science